Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival.

about

Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival.

Item

http://www.wikidata.org/entity/Q50659097

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Induction chemotherapy for T3N ...... not confer improved survival.

@en

Induction chemotherapy for T3N ...... not confer improved survival.

@nl

type

Item

label

Induction chemotherapy for T3N ...... not confer improved survival.

@en

Induction chemotherapy for T3N ...... not confer improved survival.

@nl

prefLabel

Induction chemotherapy for T3N ...... not confer improved survival.

@en

Induction chemotherapy for T3N ...... not confer improved survival.

@nl

P1476

Induction chemotherapy for T3N ...... not confer improved survival.

@en

P2093

Babatunde A Yerokun

http://www.w3.org/2001/XMLSchema#string

Betty C Tong

http://www.w3.org/2001/XMLSchema#string

Kevin L Anderson

http://www.w3.org/2001/XMLSchema#string

Mark F Berry

http://www.w3.org/2001/XMLSchema#string

Matthew G Hartwig

http://www.w3.org/2001/XMLSchema#string

Paul J Speicher

http://www.w3.org/2001/XMLSchema#string

Thomas A D'Amico

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2016

Comparison of cases captured in the national cancer data base with those in population-based central cancer registries.

Impact of neoadjuvant chemoradiotherapy followed by surgical resection on node-negative T3 and T4 non-small cell lung cancer.

Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function: a Society of Thoracic Surgeons Database analysis.

Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.

Induction chemoradiotherapy followed by surgical resection for clinical T3 or T4 locally advanced non-small cell lung cancer.

Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition).

Treatment of lung cancer.

Treatment of non-small cell lung cancer (NSCLC).

Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.

P304

370-377

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EJCTS/EZX091

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Mulvihill

P577

2017-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28402406

http://www.w3.org/2001/XMLSchema#string

P932

5848811

http://www.w3.org/2001/XMLSchema#string